Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
Cancer requires support from immune system to develop, researchers report

Cancer requires support from immune system to develop, researchers report

Researchers discover new way to attack some forms of leukemia

Researchers discover new way to attack some forms of leukemia

A new role for a critical DNA repair molecule in the immune system

A new role for a critical DNA repair molecule in the immune system

Leukaemia drug may reverse multiple sclerosis brain damage

Leukaemia drug may reverse multiple sclerosis brain damage

Gene study sheds new light on lung cancer

Gene study sheds new light on lung cancer

Getting to grips with the complexity of disease proteins

Getting to grips with the complexity of disease proteins

New hope for a better treatment for childhood cancer

New hope for a better treatment for childhood cancer

New atlas maps geographical pattern of mortality in Great Britain

New atlas maps geographical pattern of mortality in Great Britain

5 things you should know about stem cell research

5 things you should know about stem cell research

On the trail of a targeted therapy for blood cancer

On the trail of a targeted therapy for blood cancer

Battling cancer at the single cell level

Battling cancer at the single cell level

New rapid test for rare leukemia

New rapid test for rare leukemia

S*BIO initiates trials of oral JAK2 inhibitor for hematological malignancies

S*BIO initiates trials of oral JAK2 inhibitor for hematological malignancies

Discovery of promising new chemotherapy target for a deadly form of leukemia

Discovery of promising new chemotherapy target for a deadly form of leukemia

Scientists identify ependymoma genes

Scientists identify ependymoma genes

Lung cancer in non-smokers is sixth biggest cancer killer

Lung cancer in non-smokers is sixth biggest cancer killer

New ependymoma genes identified

New ependymoma genes identified

In just 5 years tobacco caused 2.4 million cases of cancer in the U.S.

In just 5 years tobacco caused 2.4 million cases of cancer in the U.S.

Public backs tougher tobacco control to protect the young

Public backs tougher tobacco control to protect the young

Antisoma commences phase II trial of AS1411 in metastatic renal cell carcinoma

Antisoma commences phase II trial of AS1411 in metastatic renal cell carcinoma